Also, rapamycin—an immunosuppressant drug that inhibits mTOR by destabilizing the mTOR–Raptor complex—controls disease progression in experimental autoimmune encephalomyelitis (EAE) mice by suppressing Teff cell functions (170, 171). Here, MTOR is linked to experimental autoimmune encephalomyelitis.